Home LiteratureArticle Details
PMID: 17534148 Published · ppublish English Journal Article

TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma.

Cell cycle (Georgetown, Tex.) ·Vol. 6 ·No. 11 ·2007-06-01 ·Pages 1360-6

Honjo Y, Bian Y, Kawakami K, Molinolo A, Longenecker G, Boppana R, Larsson J, Karlsson S, Gutkind JS, Puri RK, Kulkarni AB

Abstract

We generated a mouse model with a conditional deletion of TGF-beta signaling in the neurons by crossing TGF-beta receptor I (TbetaRI) floxed mice with neurofilament-H (NF-H) Cre mice. 35% of F1 conditional knockout (COKO) mice developed spontaneous squamous cell carcinomas (SCCs) in periorbital and/or perianal regions. Transplantation of these tumors into athymic nude mice resulted in 62% tumorigenicity. To determine whether evasion of the immune response plays any role in this tumorigenesis, we analyzed the expression levels of receptors for interleukin-13 (mIL-13R), a key negative regulator of tumor immunosurveillance, and found that 33% of COKO tumors expressed the IL-13R alpha2 chain. Primary cultures of the SCCs expressing IL-13R alpha2 were sensitive to the cytotoxic effect of IL-13R-directed cytotoxin treatment. This is the first demonstration that loss of TbetaRI can lead to spontaneous tumor formation. These mice can serve as a unique mouse model of SCC to evaluate the tumorigenicity and effect of anti-cancer therapeutics.

MeSH Terms
Activin Receptors, Type I/deficiency,genetics,physiology Animals Antineoplastic Agents/pharmacology Anus Neoplasms/genetics,immunology,metabolism Brain/embryology,metabolism Carcinoma, Squamous Cell/genetics,immunology,metabolism Cell Line, Tumor/drug effects Crosses, Genetic Drug Screening Assays, Antitumor Exotoxins/pharmacology Female Genes, Synthetic Head and Neck Neoplasms/genetics,immunology,metabolism Integrases/genetics Interleukin-13/pharmacology Interleukin-13 Receptor alpha2 Subunit/biosynthesis,genetics Male Mice Mice, Knockout Mice, Nude Neoplasm Proteins/biosynthesis,genetics Neoplasm Transplantation Neoplastic Syndromes, Hereditary/genetics Neurofilament Proteins/genetics Organ Specificity Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type I Receptors, Transforming Growth Factor beta/deficiency,genetics,physiology Recombinant Fusion Proteins/pharmacology
Chemicals
Antineoplastic Agents Exotoxins IL13-PE38 Interleukin-13 Interleukin-13 Receptor alpha2 Subunit Neoplasm Proteins Neurofilament Proteins Receptors, Transforming Growth Factor beta Recombinant Fusion Proteins neurofilament protein H Protein Serine-Threonine Kinases Activin Receptors, Type I Receptor, Transforming Growth Factor-beta Type I Cre recombinase Integrases
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Honjo Yasuyuki
Functional Genomics Section, Laboratory of Cellular and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA.
Bian Yansong
Kawakami Koji
Molinolo Alfredo
Longenecker Glenn
Boppana Ramanamurthy
Larsson Jonas
Karlsson Stefan
Gutkind J Silvio
Puri Raj K
Kulkarni Ashok B
Article Info
Journal
Cell cycle (Georgetown, Tex.)
Abbr.
Cell Cycle
ISSN
1551-4005
Published
2007-06-01
Epub
2007-00-05
Pages
1360-6
Language
English
Region
United States
NLM ID
101137841
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]